When reading a peptide monograph, it is easy to focus only on clinical outcomes and regulatory status. But between the trial result and any real-world use lies a chain of physical, chemical, and manufacturing conditions that determine whether the material in question matches what was studied. Stability, storage, cold-chain integrity, and product authenticity are not afterthoughts — they are prerequisites for any claim made about a peptide product.
This page explains those concepts from the evidence-literacy perspective. It does not give storage or handling instructions. The underlying science is documented in Lyophilization, formulation, and stability, Storage, cold chain, and beyond-use dates, and Product quality, authenticity, and testing.
Why lyophilization exists
Most peptides are insufficiently stable in aqueous solution. Lyophilization (freeze-drying) removes water by sublimation under reduced pressure, producing a porous cake that can be stored dry and rehydrated immediately before use. The process is documented in the Lyophilization page: freezing, primary drying (sublimation), and secondary drying (desorption of bound water). Each stage must be controlled precisely or the cake collapses, entraps moisture, and loses its stability advantage.
A lyophilized cake that looks elegant — uniform, no collapse, no cracks — is not a guarantee of quality, but a collapsed or cracked cake is a clear signal of process failure. The critical quality attributes include rehydration time, moisture content (target <1–2%), and the physical form of excipients. Excipients themselves serve specific roles: bulking agents like mannitol provide structure at low peptide concentrations, cryoprotectants like sucrose protect during freezing, and lyoprotectants preserve native structure during dehydration and storage.
Glass-transition temperature and storage regimes
Below its glass-transition temperature (Tg), a dried cake is a glassy solid with molecular mobility low enough to limit degradation. Above Tg, it becomes a rubbery state where degradation accelerates. Target Tg for room-temperature storage is >50°C, ideally >60°C. But moisture acts as a plasticizer — each 1% increase in residual moisture lowers Tg by 5–10°C. A cake that absorbs humidity during storage can fall below its safe temperature window without ever being visibly damaged.
The Storage page lists the labeled temperature categories: frozen (−20°C), refrigerated (2–8°C), controlled room temperature (20–25°C), and room temperature (15–30°C). The labeled condition for an approved product is validated during development under ICH Q1A guidelines. It applies to an unopened product stored under labeled conditions; it is not a generalizable rule for every vial of the same peptide sold by a different manufacturer.
Cold-chain integrity
The cold chain covers every step from manufacturing through administration: warehousing, distribution, pharmacy receipt, patient transport, and handling time outside refrigeration. Breaches can occur at any point. For refrigerated products, freezing is itself damaging — ice crystals denature peptides, cryoconcentration can cause precipitation or pH shifts, and thawing may not restore native conformation. Products labeled "Do not freeze" must be protected from unintended freezing during transport and storage.
For lyophilized products, the cake itself must stay below Tg. If the vial seal is compromised or humidity ingress occurs, the cake plasticizes and degradation accelerates. Validated cold-chain documentation uses continuous temperature monitoring — data loggers, RFID tags, or phase-change indicators — not a single reading at the time of receipt.
Beyond-use dates: not a universal rule
There is no generic beyond-use period for a rehydrated peptide. The Storage page distinguishes three concepts:
Expiration date (shelf life): assigned by the manufacturer and regulatory authority based on full stability data for an unopened product.
In-use period: determined by the manufacturer from in-use stability studies for an approved product after first opening or mixing, stated on the label.
Beyond-use date (BUD): assigned by a compounding pharmacist under applicable standards (e.g., USP <797>), based on preparation category, sterility controls, and available stability evidence.
The familiar "28-day" convention for refrigerated peptides is not a universal rule. It applies only when the specific product's label or compounding determination says so.
Product quality: what testing can and cannot tell you
A peptide product's quality is defined by critical quality attributes documented in Product quality: identity, assay (potency), purity, content uniformity, sterility, bacterial endotoxins, particulate matter, pH, and osmolality. Each has a compendial test method — HPLC for purity and identity, mass spectrometry for structural confirmation, USP <71> for sterility, USP <85> for bacterial endotoxins.
But no end-user can perform these analyses without specialized laboratory equipment, validated methods, and reference standards. Visual inspection (clarity, color, particulates) and label examination are the only checks accessible outside a laboratory, and they cannot detect chemical degradation, under-dose, or endotoxin contamination. Counterfeit peptide products — sold with false claims of identity, purity, strength, or origin — are a demonstrated problem, particularly for products sourced outside the regulated supply chain.
What this means for reading a monograph
When a monograph like semaglutide or tirzepatide records an approved product with a labeled storage condition and in-use period, that information is backed by regulatory review and validated stability data. When a monograph like BPC-157 notes that products sold as "research chemicals" are not manufactured to pharmaceutical standards, the product-quality page explains exactly what that means: purity, identity, sterility, and endotoxin levels are unverified. The scientific concepts behind that gap — lyophilization parameters, Tg, container-closure integrity, compendial testing — are not arcane details. They are the reason the atlas treats labeling, stability, and product quality as separate evidentiary layers.
For the full methodology behind stability testing and quality attributes, see Lyophilization, formulation, and stability.